SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK.
SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development.
Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply.
Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML, and radioactive iodine resistant advanced thyroid carcinoma.
SMi Reports: Leading pharmaceutical microbiologists and industry experts to meet at SMi’s 10th Anniversary Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022.
Jubilant Biosys is delighted to have Giuliano come on board as we make rapid progress in expanding our drug discovery services and CDMO business through investments in infrastructure and new capacity.
Common diseases such as gastrointestinal conditions and allergies are the focus of the company’s research and product development. More value is being added for further licensing and distribution partners through strong scientific research results. SYNformulas is seeking for additional distribution partners to expand its internationalization activities with its patented active complexes.
SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore
new approaches using X ray Microscopy (XRM) from nano- to micro-scale.
SMi Group’s reports: An expert speaker line-up, with representation from SUEZ Recycling & Recovery UK, Fortum Oslo Varme, North London Waste Authority, FCC Environment, MVV Environment, Iona Capital and many more.
SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore
new approaches using X ray Microscopy (XRM) from nano- to micro-scale.
SMi Reports: Bringing together leading experts in the industry offering insights into device innovations, connected delivery and regulatory guidance for advanced parenteral systems.
SMi Reports: Explore a future outlook of the industry with insights from leading start-ups and thought leaders on novel developments in digital medicine.
SMi Reports: As part of SMi’s leading Injectables series, this year’s event will address the key drivers of the pre-filled syringes and combination products industry.
SMi reports: Have you secured your place at Pre-filled Syringes West Coast 2021 conference returning as a virtual event in June? Now only 3 weeks away there are limited places available.
SMi Reports: Registration is open for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place 18th -19th October in London.
SMi reports: Darin Zehrung, Global Program Leader, Medical Devices and Health Technologies, PATH speaking at the upcoming Pre-filled Syringes West Coast 2021.
SMi Group are delighted to announce Christian Dechant, Director Primary Packaging & Process Development, Boehringer Ingelheim will be speaking at the Injectable Drug Delivery virtual conference taking place in May 2021.
Satisfied Users & 
Approved Press Releases
